A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
- Status
- TERMINATED
- Phase
- PHASE3
Objective Assessment of Physical Activity During Chemotherapy for Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of Stereotactic Radiotherapy for Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Tracking Physical Activity Throughout Chemotherapy for Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Fluciclovine (18F) Imaging of Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Sienna and Sentimag in Sentinel Lymph Node Biopsy
- Status
- UNKNOWN
- Phase
- NA
Everolimus TDM to Predict Long Term Toxicity
- Status
- UNKNOWN
- Phase
- N/A
Tomosynthesis (TS) or Ultrasound (US) in Mammography-negative Dense Breasts (TOMUS). National Multicenter Trial
- Status
- UNKNOWN
- Phase
- N/A
A Study Of Pembrolizumab In Combination With Trastuzumab-DM1
- Status
- COMPLETED
- Phase
- PHASE1
Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited Mobility
- Status
- COMPLETED
- Phase
- NA
Survivorship Care Plans in a Community Oncology Practice
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluation of the Short Message Service Effectiveness in the Screening Invitation Strategy for Breast Cancer (USIMaPI)
- Status
- COMPLETED
- Phase
- NA
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA